Journal article
Early Treatment of COVID-19 Disease: A Missed Opportunity
Abstract
Antivirals have demonstrated efficacy in treating other infectious diseases in early stages of disease, reducing morbidity, mortality, and the likelihood of onward transmission. At the time of writing, more than 1900 clinical trials are registered globally to assess the efficacy and safety of candidate therapeutics for COVID-19. The majority of these trials are designed to evaluate the comparative efficacy and safety of candidate therapeutics …
Authors
Forrest JI; Rayner CR; Park JJH; Mills EJ
Journal
Infectious Diseases and Therapy, Vol. 9, No. 4, pp. 715–720
Publisher
Springer Nature
Publication Date
December 2020
DOI
10.1007/s40121-020-00349-8
ISSN
2193-8229